Dublin, April 10, 2026 (GLOBE NEWSWIRE)-- The "The Principles & Applications of CRISPR (July 7, 2026)" training has been added to ResearchAndMarkets.com's offering. This course offers an in-depth ...

Ottawa, Sept. 01, 2025 (GLOBE NEWSWIRE) -- According to Precedence Research, the global CRISPR-based gene editing market size was estimated at USD 3.06 billion in 2024. It is predicted to surpass ...

Researchers at Gladstone Institutes (CA, USA) have mapped the human immune response using next-generation CRISPR technology known as base editing. Using this tool, the team was able to identify ...

CRISPR/Cas systems have undergone tremendous advancement in the past decade. These precise genome editing tools have applications ranging from transgenic crop development to gene therapy and beyond.

Researchers at Duke University and North Carolina State University have discovered a handful of new CRISPR-Cas systems that could add to the capabilities of the already transformational gene editing ...

CRISPR Therapeutics' current $5.6B market cap and $1.78B net cash position offer acquisition appeal. Click to know why CRSP ...

The type I CRISPR protein Cas3 works like Pac-Man, chomping away at a continuous stream of nucleotides with intrinsic activity for introducing targeted large deletions from a few hundred base pairs to ...

FDA sets Prescription Drug User Fee Act (PDUFA)date of March 10, 2027Positions lonvo-z to be the world’s first in vivo CRISPR-based therapy and ...

Global clinical-stage biotech company HuidaGene Therapeutics has received FDA clearance to move forward with its application for its investigational drug, a CRISPR/Cas13 RNA-editing therapy to treat ...

CRISPR, or Clustered Regularly Interspaced Short Palindromic Repeats, is an advanced technology developed in 2012 that can be used to edit genes. It can be used to find specific DNA sequences inside ...